These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 29109448)

  • 1. Identification of claudin-4 binder that attenuates tight junction barrier function by TR-FRET-based screening assay.
    Watari A; Kodaka M; Matsuhisa K; Sakamoto Y; Hisaie K; Kawashita N; Takagi T; Yamagishi Y; Suzuki H; Tsujino H; Yagi K; Kondoh M
    Sci Rep; 2017 Nov; 7(1):14514. PubMed ID: 29109448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of mucosal absorption-enhancing activity between a claudin-3/-4 binder and a broadly specific claudin binder.
    Matsuhisa K; Kondoh M; Suzuki H; Yagi K
    Biochem Biophys Res Commun; 2012 Jun; 423(2):229-33. PubMed ID: 22659740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: Evidence for direct involvement of claudins in tight junction barrier.
    Sonoda N; Furuse M; Sasaki H; Yonemura S; Katahira J; Horiguchi Y; Tsukita S
    J Cell Biol; 1999 Oct; 147(1):195-204. PubMed ID: 10508866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A claudin-4 modulator enhances the mucosal absorption of a biologically active peptide.
    Uchida H; Kondoh M; Hanada T; Takahashi A; Hamakubo T; Yagi K
    Biochem Pharmacol; 2010 May; 79(10):1437-44. PubMed ID: 20096266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Method to Prepare Claudin-Modulating Recombinant Proteins.
    Tachibana K; Kondoh M
    Methods Mol Biol; 2020; 2109():251-260. PubMed ID: 31471875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of N-terminal amino acids in the absorption-enhancing effects of the c-terminal fragment of Clostridium perfringens enterotoxin.
    Masuyama A; Kondoh M; Seguchi H; Takahashi A; Harada M; Fujii M; Mizuguchi H; Horiguchi Y; Watanabe Y
    J Pharmacol Exp Ther; 2005 Aug; 314(2):789-95. PubMed ID: 15870390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutated C-terminal fragments of Clostridium perfringens enterotoxin have increased affinity to claudin-4 and reversibly modulate tight junctions in vitro.
    Takahashi A; Kondoh M; Uchida H; Kakamu Y; Hamakubo T; Yagi K
    Biochem Biophys Res Commun; 2011 Jul; 410(3):466-70. PubMed ID: 21672529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of C-terminal regions of the C-terminal fragment of Clostridium perfringens enterotoxin in its interaction with claudin-4.
    Takahashi A; Kondoh M; Masuyama A; Fujii M; Mizuguchi H; Horiguchi Y; Watanabe Y
    J Control Release; 2005 Nov; 108(1):56-62. PubMed ID: 16091298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naringenin enhances intestinal barrier function through the expression and cytoskeletal association of tight junction proteins in Caco-2 cells.
    Noda S; Tanabe S; Suzuki T
    Mol Nutr Food Res; 2013 Nov; 57(11):2019-28. PubMed ID: 23868418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel strategy for the enhancement of drug absorption using a claudin modulator.
    Kondoh M; Masuyama A; Takahashi A; Asano N; Mizuguchi H; Koizumi N; Fujii M; Hayakawa T; Horiguchi Y; Watanbe Y
    Mol Pharmacol; 2005 Mar; 67(3):749-56. PubMed ID: 15602007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific binding of Clostridium perfringens enterotoxin fragment to Claudin-b and modulation of zebrafish epidermal barrier.
    Zhang J; Ni C; Yang Z; Piontek A; Chen H; Wang S; Fan Y; Qin Z; Piontek J
    Exp Dermatol; 2015 Aug; 24(8):605-10. PubMed ID: 25869230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity of Clostridium perfringens enterotoxin depends on the conditions of claudin-4 in ovarian carcinoma cells.
    Tanaka S; Aoyama T; Ogawa M; Takasawa A; Murata M; Osanai M; Saito T; Sawada N
    Exp Cell Res; 2018 Oct; 371(1):278-286. PubMed ID: 30142326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Claudin-4 overexpression in epithelial ovarian cancer is associated with hypomethylation and is a potential target for modulation of tight junction barrier function using a C-terminal fragment of Clostridium perfringens enterotoxin.
    Litkouhi B; Kwong J; Lo CM; Smedley JG; McClane BA; Aponte M; Gao Z; Sarno JL; Hinners J; Welch WR; Berkowitz RS; Mok SC; Garner EI
    Neoplasia; 2007 Apr; 9(4):304-14. PubMed ID: 17460774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GLP-2 enhances barrier formation and attenuates TNFα-induced changes in a Caco-2 cell model of the intestinal barrier.
    Moran GW; O'Neill C; McLaughlin JT
    Regul Pept; 2012 Oct; 178(1-3):95-101. PubMed ID: 22809889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Tyr306 in the C-terminal fragment of Clostridium perfringens enterotoxin for modulation of tight junction.
    Ebihara C; Kondoh M; Harada M; Fujii M; Mizuguchi H; Tsunoda S; Horiguchi Y; Yagi K; Watanabe Y
    Biochem Pharmacol; 2007 Mar; 73(6):824-30. PubMed ID: 17169334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for
    Vecchio AJ; Rathnayake SS; Stroud RM
    Proc Natl Acad Sci U S A; 2021 Apr; 118(15):. PubMed ID: 33876770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Domain mapping of a claudin-4 modulator, the C-terminal region of C-terminal fragment of Clostridium perfringens enterotoxin, by site-directed mutagenesis.
    Takahashi A; Komiya E; Kakutani H; Yoshida T; Fujii M; Horiguchi Y; Mizuguchi H; Tsutsumi Y; Tsunoda S; Koizumi N; Isoda K; Yagi K; Watanabe Y; Kondoh M
    Biochem Pharmacol; 2008 Apr; 75(8):1639-48. PubMed ID: 18342294
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Cuellar P; Hernández-Nava E; García-Rivera G; Chávez-Munguía B; Schnoor M; Betanzos A; Orozco E
    Front Cell Infect Microbiol; 2017; 7():372. PubMed ID: 28861400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel strategy for a drug delivery system using a claudin modulator.
    Kondoh M; Takahashi A; Fujii M; Yagi K; Watanabe Y
    Biol Pharm Bull; 2006 Sep; 29(9):1783-9. PubMed ID: 16946486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An intestinal paracellular pathway biased toward positively-charged macromolecules.
    Almansour K; Taverner A; Turner JR; Eggleston IM; Mrsny RJ
    J Control Release; 2018 Oct; 288():111-125. PubMed ID: 30194947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.